Retraction: MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer (PLoS ONE (2015) 10:2 (e0118086) DOI: 10.1371/journal.pone.0118086);MicroRNA-214 suppresses oncogenesis and exerts impact on prognosis by targeting PDRG1 in bladder cancer

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Wang, Jinfeng ^a,b   Zhang, Xin ^a   Wang, Lili ^a   Yang, Yongmei ^a   Dong, Zhaogang ^a   Wang, Haiyan ^a   Du, Lutao ^a   Wang, Chuanxin ^a  

^a SHANDONG UNIVERSITY   (China)

^b LINYI PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 214; ONCOPROTEIN; PDRG1 PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; MICRORNA; MIRN214 MICRORNA, HUMAN; PDRG1 PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; BLADDER CANCER; BLADDER CANCER CELL LINE; CANCER GRADING; CANCER INHIBITION; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIGRATION INHIBITION; NON MUSCLE INVASIVE BLADDER CANCER; OVERALL SURVIVAL; PROTEIN TARGETING; RECURRENCE FREE SURVIVAL; TUMOR INVASION; BLADDER; BLADDER TUMOR; CELL LINE; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

CARCINOGENESIS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84923378801     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0244274     Document Type: Erratum

References (39)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63: 11-30. doi: 10.3322/caac.21166 PMID: 23335087
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90. doi: 10.3322/caac.20107 PMID: 21296855
3. Babjuk M, OosterlinckW, Sylvester R, Kaasinen E, Bohle A, Palou-Redorta J, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol. 2011; 59: 997-1008. doi: 10.1016/j.eururo.2011.03.017 PMID: 21458150
4. Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009; 374: 239-249. doi: 10.1016/S0140-6736(09)60491-8 PMID: 19520422
5. Pollard C, Smith SC, Theodorescu D. Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC). Expert Rev Mol Med. 2010; 12: e10. doi: 10.1017/S1462399410001407 PMID: 20334706
6. Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010; 11: 252-263. doi: 10.1038/nrm2868 PMID: 20216554
7. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136: 215-233. doi: 10.1016/j.cell.2009.01.002 PMID: 19167326
8. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of micro-RNAs. Genome Res. 2009; 19: 92-105. doi: 10.1101/gr.082701.108 PMID: 18955434
9. Schickel R, Boyerinas B, Park SM, Peter ME. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene. 2008; 27: 5959-5974. doi: 10.1038/onc.2008.274 PMID: 18836476
10. Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell. 2009; 136: 586-591. doi: 10.1016/j.cell.2009.02.005 PMID: 19239879
11. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. Lancet Oncol. 2012; 13: e249-258. doi: 10.1016/S1470-2045(12)70073-6 PMID: 22652233
12. Bartels CL, Tsongalis GJ. MicroRNAs: novel biomarkers for human cancer. Clin Chem. 2009; 55: 623-631. doi: 10.1373/clinchem.2008.112805 PMID: 19246618
13. Hirata H, Hinoda Y, Ueno K, Shahryari V, Tabatabai ZL, Dahiya R. MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. Carcinogenesis. 2012; 33: 41-48. doi: 10.1093/carcin/bgr239 PMID: 22049531
14. Ueno K, Hirata H, Majid S, Yamamura S, Shahryari V, Tabatabai ZL, et al. Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4. Mol Cancer Ther. 2012; 11: 244-253. doi: 10.1158/1535-7163.MCT-11-0592 PMID: 22057916
15. Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A, et al. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Int J Cancer. 2013; 132: 2479-2491. doi: 10.1002/ijc.27949 PMID: 23169479
16. Villadsen SB, Bramsen JB, Ostenfeld MS, Wiklund ED, Fristrup N, Gao S, et al. The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. Br J Cancer. 2012; 106: 366-374. doi: 10.1038/bjc.2011.520 PMID: 22108519
17. Dyrskjot L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R, et al. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res. 2009; 69: 4851-4860. doi: 10.1158/0008-5472.CAN-08-4043 PMID: 19487295
18. Penna E, Orso F, Cimino D, Vercellino I, Grassi E, Quaglino E, et al. miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation. Cancer Res. 2013; 73: 4098-4111. doi: 10.1158/0008-5472.CAN-12-3686 PMID: 23667173
19. Penna E, Orso F, Cimino D, Tenaglia E, Lembo A, Quaglino E, et al. microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J. 2011; 30: 1990-2007. doi: 10.1038/emboj.2011.102 PMID: 21468029
20. Peng RQ, Wan HY, Li HF, Liu M, Li X, Tang H. MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7. J Biol Chem. 2012; 287: 14301-14309. doi: 10.1074/jbc.M111.337642 PMID: 22399294
21. Derfoul A, Juan AH, Difilippantonio MJ, Palanisamy N, Ried T, Sartorelli V. Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase. Carcinogenesis. 2011; 32: 1607-1614. doi: 10.1093/carcin/bgr184 PMID: 21828058
22. Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC, Huang CH, et al. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol. 2012; 57: 584-591. doi: 10.1016/j.jhep.2012.04.031 PMID: 22613005
23. Song T, Xia W, Shao N, Zhang X, Wang C, Wu Y, et al. Differential miRNA expression profiles in bladder urothelial carcinomas. Asian Pac J Cancer Prev. 2010; 11: 905-911. PMID: 21133599
24. Ratert N, Meyer HA, Jung M, Lioudmer P, Mollenkopf HJ, Wagner I, et al. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome. J Mol Diagn. 2013; 15: 695-705. doi: 10.1016/j.jmoldx.2013.05.008 PMID: 23945108
25. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors. New York: Wiley-Blackwell; 2009.
26. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs. Lyon (France): IARC Press; 2004.
27. Metalli D, Lovat F, Tripodi F, Genua M, Xu SQ, Spinelli M, et al. The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin. Am J Pathol. 2010; 176: 2997-3006. doi: 10.2353/ajpath.2010.090904 PMID: 20395438
28. Huang SD, Yuan Y, Zhuang CW, Li BL, Gong DJ, Wang SG, et al. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. Mol Cancer. 2012; 11: 51. doi: 10.1186/1476-4598-11-51 PMID: 22867052
29. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010; 11: 136-146. doi: 10.1016/S1470-2045(09)70343-2 PMID: 20022810
30. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 2008; 68: 425-433. doi: 10.1158/0008-5472.CAN-07-2488 PMID: 18199536
31. Xu CX, Xu M, Tan L, Yang H, Permuth-Wey J, Kruk PA, et al. MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog. J Biol Chem. 2012; 287: 34970-34978. doi: 10.1074/jbc.M112.374611 PMID: 22927443
32. Deng M, Ye Q, Qin Z, Zheng Y, He W, Tang H, et al. miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma. Tumour Biol. 2013; 34: 1793-1800. doi: 10.1007/s13277-013-0718-y PMID: 23479198
33. Lujambio A, Lowe SW. The microcosmos of cancer. Nature. 2012; 482: 347-355. doi: 10.1038/nature10888 PMID: 22337054
34. Cao Q, Mani RS, Ateeq B, Dhanasekaran SM, Asangani IA, Prensner JR, et al. Coordinated regulation of polycomb group complexes through microRNAs in cancer. Cancer Cell. 2011; 20: 187-199. doi: 10.1016/j.ccr.2011.06.016 PMID: 21840484
35. Kim SM, Kang HW, Kim WT, Kim YJ, Yun SJ, Lee SC, et al. Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer. Korean J Urol. 2013; 54: 791-796. doi: 10.4111/kju.2013.54.11.791 PMID: 24255763
36. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-674. doi: 10.1016/j.cell.2011.02.013 PMID: 21376230
37. Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, et al. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer. 2011; 104: 808-818. doi: 10.1038/bjc.2011.23 PMID: 21304530
38. Jiang L, Luo X, Shi J, Sun H, Sun Q, Sheikh MS, et al. PDRG1, a novel tumor marker for multiple malignancies that is selectively regulated by genotoxic stress. Cancer Biol Ther. 2011; 11: 567-573. PMID: 21193842
39. Luo X, Huang Y, Sheikh MS. Cloning and characterization of a novel gene PDRG that is differentially regulated by p53 and ultraviolet radiation. Oncogene. 2003; 22: 7247-7257. PMID: 14562055